- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 277/24 - Radicals substituted by oxygen atoms
Patent holdings for IPC class C07D 277/24
Total number of patents in this class: 297
10-year publication summary
|
16
|
15
|
21
|
16
|
18
|
20
|
14
|
12
|
10
|
7
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4884 |
10 |
| Oncternal Therapeutics, Inc. | 36 |
9 |
| The University of Toledo | 425 |
8 |
| Acucela Inc. | 160 |
7 |
| Avexxin AS | 46 |
7 |
| Gilead Sciences, Inc. | 2038 |
7 |
| University of Tennessee Research Foundation | 758 |
7 |
| Bayer Intellectual Property GmbH | 2496 |
6 |
| Sumitomo Chemical Company, Limited | 9049 |
6 |
| Toray Industries, Inc. | 6951 |
6 |
| Kyoto University | 2802 |
6 |
| F. Hoffmann-La Roche AG | 7920 |
4 |
| Boehringer Ingelheim International GmbH | 4644 |
4 |
| Abbvie Inc. | 1800 |
4 |
| Daiichi Sankyo Company, Limited | 1874 |
4 |
| Centre National de La Recherche Scientifique | 10442 |
3 |
| Agency for Science, Technology and Research | 3627 |
3 |
| The Board of Trustees of the University of Illinois | 2695 |
3 |
| Atrogi AB | 53 |
3 |
| Genzyme Corporation | 1263 |
3 |
| Other owners | 187 |